Scisparc receives approval to conduct its clinical trial in children with autism spectrum disorder at the soroka medical center

The company has already secured approvals from ethics committee and israeli ministry of health for the company's study with its proprietary sci-210 treatment
SPRC Ratings Summary
SPRC Quant Ranking